医療用酸素の世界市場-2022-2029

市場力学

医療用酸素の世界市場は、喘息、COPD、肺がんなど、深刻な健康問題につながる、あるいは死に至る可能性のある呼吸器系疾患の発生率の上昇など、さまざまな要因によって成長しています。

呼吸器系疾患の発生率の増加や技術の進歩の急増は、市場の成長を促進すると予想されます。

市場の成長に役立つ主要な促進要因は、科学技術の進歩の上昇、呼吸器疾患の発生率の増加と新規製品の発売を増加させることです。

世界保健機関（WHO）の報告書2022年によると、2019年の慢性閉塞性肺疾患（COPD）は約323万人の死亡を引き起こし、世界の死亡の第3の主な原因になっています。70歳未満のCOPDによる死亡の約90％は、低・中所得国で起こっています。医療用酸素市場は、呼吸器疾患の有病率の増加や、世界各地のさまざまな斬新な技術的改善によって牽引されています。喘息、肺がん、肺炎、COPDなど、さまざまな種類の呼吸器疾患には、薬物療法によってコントロールまたは予防できるものと死に至る可能性があるものとで、危険因子が異なっています。COPDや肺炎などの慢性肺疾患は、加齢に伴い呼吸筋力が低下するため、高齢者層での有病率が高いとされています。

喫煙やタバコなどのライフスタイルの変化により、慢性閉塞性肺疾患（COPD）や喘息などの有病率が高まっています。慢性閉塞性肺疾患（COPD）は、息苦しさの原因となり、増悪して重症化しやすく、生命を脅かす進行性の慢性肺疾患です。世界保健機関（WHO）によると、2020年には世界で約2億5100万人が慢性閉塞性肺疾患（COPD）に罹患するといわれています。肥満とタバコの消費量の増加が、喘息、COPD、OSAの世界の有病率の上昇に主に寄与しており、これが世界の医療用酸素市場に拍車をかけることになります。環境汚染の高まりにより、COPDや喘息などの呼吸器系疾患の発症が急増し、酸素療法の需要が高まっています。

様々な斬新な進歩は、そのようなコラボレーション、合併または市場で新製品をリリースする主要なプレーヤーによって行われています。例えば、2021年にジョンソン＆ジョンソンビジョンケアによって開発されたアキュビューオアシスとして知られている医療酸素は、快適さを提供し、高い水分含量を有し、明確なビジョンと目の健康を維持するFDAによって承認されました。

これらの医療用酸素システムに関連する高コストは、市場の成長を妨げると予想されます。

これらの医療用酸素システムとそのメンテナンスの高コストはまた、それは非常に高価になります。2019年に「酸素デバイスとデリバリーシステム」と題された記事では、「酸素流量設定とユニットのサイズに左右される、設定された頻度での液体酸素定置システムの再充填に関連する高いサービスコストがある」と記載されています。

COVID-19影響度分析

COVID-19はあらゆる分野に影響を及ぼしましたが、医療用酸素の市場成長の主な要因となっています。

COVID-19の症例の多くは重症で、治療のために医療用酸素を必要としたためです。このため、人工呼吸器、酸素ボンベ、壁掛け型酸素濃縮器、缶入り酸素の需要が、病院だけでなく在宅医療においても世界的に急増しています。医療用酸素システムの需要はCOVID-19の流行によって影響を受け、需要が増加したため、世界的に医療用人工呼吸器が不足することになりました。このため、科学者や生物医学エンジニアは、酸素濃縮器や手動式蘇生器など、すでに利用可能な機器を使って人工呼吸器の一般的な機能を模倣する代替機器を開発しています。米国では、FDAが緊急時使用許可プログラムに基づいて酸素濃縮器の使用を許可したため、予測期間中の医療用酸素機器の需要が高まっています。

本レポートでは、約45以上の市場データ表、40以上の図表、180ページにわたる情報を提供しています。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

• 市場インパクトファクター
  • 促進要因
    • 呼吸器疾患の急増とホームケア製品の進化
  • 抑制要因
    • 医療用酸素機器の高コスト
  • 市場機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース
• 規制分析
• サプライチェーン分析
• 価格設定分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的な取り組み
• まとめ

第7章 製品タイプ別

• 酸素濃縮器
• 圧縮酸素ボンベ
• 液体酸素システム
• 人工呼吸器
• HFNC

第8章 酸素供給システム別

• 低流量システム
• ハイフローシステム

第9章 モード別酸素濃度

• 門脈型酸素
• 定置用酸素

第10章 用途別

• 肺疾患
• 喘息
• 心不全
• 嚢胞性線維症
• 気管支肺疾患
• その他

第11章 エンドユーザー別

• 病院
• 救急医療センター
• 外来診療センター
• コミュニティケア
• 高気圧治療室
• 在宅医療
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第13章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第14章 企業プロファイル

• Inogen Incorporation
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Precision Medical, Inc.
• ResMed Inc.
• Besco Medical Co. Ltd.
• Koninklijke Philips N.V
• Luxfer Group
• Invacare Corporation
• O2 Concepts LLC.
• Responsive Respiratory
• GCE Group

第15章 医療用酸素の世界市場-DataM

Market Overview

Medical Oxygen Market size was valued US$ 2,893.53 million in 2021 and is estimated to reach US$ 5,516.82 million by 2029, growing at a CAGR of 7.47% during the forecast period (2022-2029).

Oxygen is used as a life-saving gas that plays crucial role in treatment of patients during surgery, heart failure or trauma. It is a very complex compound and its production takes place in industrial plants. Medical oxygen is the use of oxygen for medical treatment. Oxygen is taken from the air that is purified and compressed to treat patients with respiratory disorders.

Market Dynamics

The global medical oxygen market growth is driven by various factors such as rising incidences of respiratory disorders like asthma, COPD, lung cancer that may lead to severe health issues or can even result in death.

Increasing incidence of respiratory disorders and surge in technological advances are expected to drive the growth of market.

The major drivers helping in the growth of the market are the rise in the scientific and technological advances, increasing incidence of respiratory disease and increasing the novel product launch.

According to World Health Organisation report 2022, chronic obstructive pulmonary disease (COPD) in 2019 caused around 3.23 million deaths and became third main cause for global deaths. Approximately 90% of COPD deaths under 70 years of age takes place in countries with low or middle income. The medical oxygen market is being driven by the increasing prevalence of respiratory disorders and various novel technological improvements across the globe. Different types of respiratory disorders such as asthma, lung cancer, pneumonia, COPD and others have different risk factors where some can be controlled or prevented through drug therapies and others may lead to death. The prevalence of chronic lung disorders such as COPD and pneumonia is high among the older population as respiratory muscle strength decreases as age progresses.

The rising prevalence of chronic obstructive pulmonary disease (COPD) and Asthma owing to the changing lifestyle, including smoking, tobacco consumption, and others. Chronic obstructive pulmonary disease (COPD) is a progressive, chronic life-threatening lung disease that causes breathlessness and predisposes to exacerbations and serious illness. According to the World Health Organization (WHO) in 2020, around 251 million people suffer from Chronic obstructive pulmonary disease (COPD) worldwide. Obesity and increased tobacco consumption are mainly contributing to the rise in the prevalence of asthma, COPD, and OSA globally, which will fuel the global medical oxygen market. The rising environmental pollution has caused a spike in the incidence of COPD, asthma, and other respiratory diseases, leading to an increased demand for oxygen therapy.

Various novel advancements are being done by key players such collaborations, mergers or releasing new products in market. For instance, in 2021 Medical Oxygen known as Acuvue Oasys developed by Johnson and Johnson Vision Care got approved by FDA that provides comfort, have high moisture content, clear vision and maintains good health of eye.

High cost associated with these medical oxygen systems is expected to hamper the market growth.

The high cost of these medical oxygen systems and their maintenance also makes it quite expensive. In 2019 an article titled "Oxygen devices and delivery systems" stated that "There is a high service cost associated with refilling the liquid oxygen stationary systems at a set frequency, contingent on the oxygen flow setting and the unit's size".

COVID-19 Impact Analysis

COVID-19 affected all the fields but it's the main factor for growth in the market of medical oxygen

as majority of COVID-19 cases were severe and needed medical oxygen for treatment. Due to this artificial ventilation, oxygen cylinders, wall-mounted oxygen concentrators and canned oxygen demand increased suddenly in hospitals as well in home care globally. Demand of the medical oxygen systems has been impacted by COVID-19 pandemic, as demand increased and this led to the scarcity of medical ventilators worldwide. To control this, scientists and biomedical engineers have developed substitute devices that will mimic the general functions of ventilators using devices that are already available such as oxygen concentrators and manual resuscitators. In U.S., the FDA permitted using the oxygen concentrators under a program Emergency Use Authorization hence enhancing the demand of the medical oxygen devices in forecast period.

Segment Analysis

Oxygen concentrator segment is expected to hold the largest market share in global medical oxygen market

Oxygen Concentrators segment is expected to hold the largest market share in global medical oxygen market as it's the most used product worldwide. It is efficient to use hence people tend to use it and hence rise in demand. Oxygen concentrators provides oxygen-enriched air that is safe. Oxygen concentrators are devices that takes up the room air that passes through a series of filters which remove dust, bacteria and other particulates. It is a two steps concentration process where in the first step the machine forces air in one cylinder that contains semi-permeable membranes, nitrogen gets absorbed here, that leaves concentrated oxygen (90% or higher) and small amounts of other gases. At the exact time, in the second cylinder, nitrogen gets desorbed and drawn out. In second step, the task of cylinders is reversed in a timed cycle, that provides a continuous flow of oxygen to patient. General oxygen concentrator delivers the oxygen flows of around 0.5-5 L*min-1 (low-flow oxygen concentrators), but some other models can achieve up to 10 L*min-1 (high-flow oxygen concentrators). Such kind of devices are easy to carry and use.

According to an article titled "Oxygen devices and delivery systems" the portable oxygen concentrators are the latest technology for long term oxygen therapy users who desire a small, lightweight and portable oxygen solution in a compact and mobile unit. These concentrators use electrical power hence supply oxygen in unlimited amount and are more cost effective as only need charging.

There is an increase in the number of companies developing the medical oxygen systems such as Inogen Inc., Medtronic, Airgas Inc., Koninklijke Philips, Linde group, Sol groups etc are the major players that are manufacturing novel Medical Oxygen. For instance, in Apr 2020, Linde announced its novel contract with the Indian Oil Corporation Limited, India's biggest refiner that has strengthened its portfolio of extensive technology.

Geographical Analysis

North America region holds the largest market share in the global medical oxygen market

The North America region is expected to lead the market in the upcoming future. Factors such as pervasiveness of respiratory disorders such as asthma, pneumonia, lung cancer, COPD and novel developments in technology are likely to increase the market growth. Currently almost 25 million people have asthma in the United States. COPD have been diagnosed in around 14.8 million adults. Annual expenditures on health care for asthma are estimated around $20.7 billion. In U.S., the FDA permitted using the oxygen concentrators under a program Emergency Use Authorization hence enhancing the demand of the medical oxygen devices.

Major key players are developing novel scientific and advanced technologies to meet the needs of users and provide them with efficient products. For instance, in April 2019, FDA approved Supersaturated oxygen therapy introduced by TherOx that is used to treat the damaged heart tissue safely. Some of the key players are developing mobile apps for convenience of users. due to which this region holds the largest market share in global medical oxygen market.

In Feb 2021, SOL Group, manufacturer of pure medical and technical gases announced that it has acquired Air Liquide Hellas, medical gases and technical gases company operative in Greek market.

Competitive Landscape

The global orthokeratology market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Some of the major key players in the global medical oxygen market are Inogen Incorporation, Precision Medical, Inc., ResMed Inc., Besco Medical Co. Ltd., Koninklijke Philips N.V, Luxfer Group, Invacare Corporation, O2 Concepts LLC., Responsive Respiratory, GCE Group. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in 2021, UNICEF collaborated with The Oxygen CoLab and NEST360 to drive the production of flexible oxygen concentrator for less resource surroundings.

The key companies are focusing on key strategies such as collaboration, acquisitions, and product launches which are boosting the growth of the market globally. For instance,

• In Sep 2022, Responsive Respiratory, a manufacturer of high-pressure oxygen products announced its partnership agreement with Boost Oxygen, provider of products related to respiratory support. With this agreement RRI will distribute Boost Oxygen products.
• In Apr 2021, ResMed, company that develops medical devices related to cloud connect and digital health announced its AirView expansion for the ventilation. It is a cloud-based management platform for patients of respiratory care.
• In Jan 2021, SOL Groups increased its stake in SICGILSOL its Indian joint venture for expanding its availability in Indian market of medical and technical gases.
• In Jun 2020, GCE Healthcare launched Clarity connect care, an online platform for monitoring on its portable oxygen concentrator Zen-O life. Zen-O-life is used for improved management of oxygen therapy of patients with chronic respiratory disease such as COPD in homecare setting.
• In Jun 2020, Medtronic announced its partnership with Foxconn Industrial for production of ventilators. All the regulatory and quality requirements were completed by Foxconn and started Medtronic's ventilator Puritan Bennett 560 manufacturing in United States.

Key Companies to Watch

Inogen Inc.:

Overview: Inogen is a company that deals with medical technologies and manufactures various respiratory products that are generally used in homecare. Their primary products are portable oxygen concentrators that are being used for chronic respiratory conditions suffering patients as it provides long term oxygen therapy. These concentrators are being manufactured and marketed with new advancements in around 57 countries. It was founded in 2001, and is headquartered in California, U.S.

Product Portfolio:

Inogen One G5: It is a portable oxygen concentrator that provides extreme oxygen per pound. It's dense, small and lightly weighted with varying settings of flow for 1-6 that can be used 24 hours.This modal is so efficient and contains easy control functions with LCD displays that is convenient to read. For instance, in 2020 a report tiltled "Oxygen monitoring and control system" stated that "The Inogen One G5 provides 1 LPM continuous at a setting of 6 with 17 breaths minute that is very efficient as compared to others."

Key Developments: In Sep 2021, Inogen, company of medical technology with innovative respiratory products announced its agreement with Ashfield Healthcare to expand its market capabilities.

The global medical oxygen market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The surge in occurrence of the respiratory disorders and new advances in home care product
  • 4.1.2. Restraints:
    • 4.1.2.1. High cost of these medical oxygen devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces
• 5.2. Regulatory Analysis
• 5.3. Supply Chain Analysis
• 5.4. Pricing Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type Segment
• 7.2. Oxygen Concentrator
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Compressed Oxygen Cylinder
• 7.4. Liquid Oxygen Systems
• 7.5. Ventilators
• 7.6. HFNC

8. By System of Oxygen Delivery

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 8.1.2. Market Attractiveness Index, By System of Oxygen Delivery Segment
• 8.2. Low Flow Systems
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. High Flow Systems

9. By Modal Quality

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 9.1.2. Market Attractiveness Index, By Modal Quality Segment
• 9.2. Portal Oxygen
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Stationary Oxygen

10. By Applications

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 10.1.2. Market Attractiveness Index, By Applications Segment
• 10.2. Lung Disorders
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Asthma
• 10.4. Heart Failure
• 10.5. Cystic Fibrosis
• 10.6. Bronchopulmonary Disorder
• 10.7. Other

11. By End user

• 11.1. Introduction
  • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 11.1.2. Market Attractiveness Index, By End user Segment
• 11.2. Hospitals
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 11.3. Emergency Medical Centers
• 11.4. Ambulatory Centers
• 11.5. Community Care
• 11.6. Hyperbaric Chambers
• 11.7. Home Care
• 11.8. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.2.8.1. U.S.
    • 12.2.8.2. Canada
    • 12.2.8.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.3.8.1. Germany
    • 12.3.8.2. U.K.
    • 12.3.8.3. France
    • 12.3.8.4. Italy
    • 12.3.8.5. Spain
    • 12.3.8.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.4.8.1. Brazil
    • 12.4.8.2. Argentina
    • 12.4.8.3. Rest of South America
• 12.5. Asia Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.5.8.1. China
    • 12.5.8.2. India
    • 12.5.8.3. Japan
    • 12.5.8.4. Australia
    • 12.5.8.5. Rest of Asia Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4.
  • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
  • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
  • 12.6.7.
  • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
  • 12.6.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

13. Competitive Landscape

• 13.1. Key Developments and Strategies
• 13.2. Company Share Analysis
• 13.3. Product Benchmarking
• 13.4. List of Key Companies to Watch

14. Company Profiles

• 14.1. Inogen Incorporation
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio and Description
  • 14.1.3. Key Highlights
  • 14.1.4. Financial Overview
• 14.2. Precision Medical, Inc.
• 14.3. ResMed Inc.
• 14.4. Besco Medical Co. Ltd.
• 14.5. Koninklijke Philips N.V
• 14.6. Luxfer Group
• 14.7. Invacare Corporation
• 14.8. O2 Concepts LLC.
• 14.9. Responsive Respiratory
• 14.10. GCE Group

LIST NOT EXHAUSTIVE

15. Global Medical Oxygen Market - DataM

• 15.1 Appendix
• 15.2 About Us
• 15.3 Contact Us